N-[(2S)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(2R)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(4-chlorophenyl)methyl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-(2-propoxypyrimidin-5-yl)pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-(2,2,2-trifluoroethoxy)pyrimidin-5-yl]pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-[2-(trifluoromethoxy)ethoxy]pyrimidin-5-yl]pyridazin-1-yl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-[(2-methylphenyl)methyl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-phenylcyclobutyl)acetamide

C143H144ClF16N35O25 — CID 159013433

About N-[(2S)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(2R)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(4-chlorophenyl)methyl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-(2-propoxypyrimidin-5-yl)pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-(2,2,2-trifluoroethoxy)pyrimidin-5-yl]pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-[2-(trifluoromethoxy)ethoxy]pyrimidin-5-yl]pyridazin-1-yl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-[(2-methylphenyl)methyl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-phenylcyclobutyl)acetamide

N-[(2S)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(2R)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(4-chlorophenyl)methyl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-(2-propoxypyrimidin-5-yl)pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-(2,2,2-trifluoroethoxy)pyrimidin-5-yl]pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-[2-(trifluoromethoxy)ethoxy]pyrimidin-5-yl]pyridazin-1-yl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-[(2-methylphenyl)methyl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-phenylcyclobutyl)acetamide (PubChem CID 159013433) has the molecular formula C143H144ClF16N35O25 and a molecular weight of 3092.37 g/mol. Its IUPAC name is N-[(2S)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(2R)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(4-chlorophenyl)methyl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-(2-propoxypyrimidin-5-yl)pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-(2,2,2-trifluoroethoxy)pyrimidin-5-yl]pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-[2-(trifluoromethoxy)ethoxy]pyrimidin-5-yl]pyridazin-1-yl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-[(2-methylphenyl)methyl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-phenylcyclobutyl)acetamide.

Molecular Properties

• Compound Name: N-[(2S)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(2R)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(4-chlorophenyl)methyl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-(2-propoxypyrimidin-5-yl)pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-(2,2,2-trifluoroethoxy)pyrimidin-5-yl]pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-[2-(trifluoromethoxy)ethoxy]pyrimidin-5-yl]pyridazin-1-yl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-[(2-methylphenyl)methyl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-phenylcyclobutyl)acetamide
• PubChem CID: 159013433
• Molecular Formula: C143H144ClF16N35O25
• Molecular Weight: 3092.37 g/mol
• Exact Mass: 3090.05
• IUPAC Name: N-[(2S)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(2R)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(4-chlorophenyl)methyl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-(2-propoxypyrimidin-5-yl)pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-(2,2,2-trifluoroethoxy)pyrimidin-5-yl]pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-[2-(trifluoromethoxy)ethoxy]pyrimidin-5-yl]pyridazin-1-yl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-[(2-methylphenyl)methyl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-phenylcyclobutyl)acetamide
• SMILES: CCCOc1ncc(-c2ccc(=O)n(CC(=O)NC3CCC3)n2)cn1.CC[C@@H](C)NC(=O)Cn1nc(-c2ccc(OC(F)F)nc2)ccc1=O.CC[C@H](C)NC(=O)Cn1nc(-c2ccc(OC(F)F)nc2)ccc1=O.Cc1ccccc1CNC(=O)Cn1nc(-c2ccc(OC(F)F)nc2)ccc1=O.O=C(Cn1nc(-c2ccc(OC(F)F)nc2)ccc1=O)NC1(c2ccccc2)CCC1.O=C(Cn1nc(-c2ccc(OC(F)F)nc2)ccc1=O)NCc1ccc(Cl)cc1.O=C(Cn1nc(-c2cnc(OCC(F)(F)F)nc2)ccc1=O)NC1CCC1.O=C(Cn1nc(-c2cnc(OCCOC(F)(F)F)nc2)ccc1=O)NC1CCC1
• InChI: InChI=1S/C22H20F2N4O3.C20H18F2N4O3.C19H15ClF2N4O3.C17H18F3N5O4.C17H21N5O3.C16H16F3N5O3.2C16H18F2N4O3/c23-21(24)31-19-9-7-15(13-25-19)17-8-10-20(30)28(27-17)14-18(29)26-22(11-4-12-22)16-5-2-1-3-6-16;1-13-4-2-3-5-14(13)10-23-17(27)12-26-19(28)9-7-16(25-26)15-6-8-18(24-11-15)29-20(21)22;20-14-4-1-12(2-5-14)9-23-16(27)11-26-18(28)8-6-15(25-26)13-3-7-17(24-10-13)29-19(21)22;18-17(19,20)29-7-6-28-16-21-8-11(9-22-16)13-4-5-15(27)25(24-13)10-14(26)23-12-2-1-3-12;1-2-8-25-17-18-9-12(10-19-17)14-6-7-16(24)22(21-14)11-15(23)20-13-4-3-5-13;17-16(18,19)9-27-15-20-6-10(7-21-15)12-4-5-14(26)24(23-12)8-13(25)22-11-2-1-3-11;2*1-3-10(2)20-13(23)9-22-15(24)7-5-12(21-22)11-4-6-14(19-8-11)25-16(17)18/h1-3,5-10,13,21H,4,11-12,14H2,(H,26,29);2-9,11,20H,10,12H2,1H3,(H,23,27);1-8,10,19H,9,11H2,(H,23,27);4-5,8-9,12H,1-3,6-7,10H2,(H,23,26);6-7,9-10,13H,2-5,8,11H2,1H3,(H,20,23);4-7,11H,1-3,8-9H2,(H,22,25);2*4-8,10,16H,3,9H2,1-2H3,(H,20,23)/t;;;;;;2*10-/m......10/s1
• InChIKey: JSUAIZUCVRFDSY-DPHLWUGDSA-N
• XLogP: 15.91
• TPSA: 736.78 Ų
• H-Bond Donors: 8
• H-Bond Acceptors: 52
• Rotatable Bonds: 56
• Heavy Atoms: 220
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3092.37
LogP ≤ 5	15.91
H-Bond Donors ≤ 5	8
H-Bond Acceptors ≤ 10	52

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of N-[(2S)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(2R)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(4-chlorophenyl)methyl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-(2-propoxypyrimidin-5-yl)pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-(2,2,2-trifluoroethoxy)pyrimidin-5-yl]pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-[2-(trifluoromethoxy)ethoxy]pyrimidin-5-yl]pyridazin-1-yl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-[(2-methylphenyl)methyl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-phenylcyclobutyl)acetamide?

The IUPAC name of N-[(2S)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(2R)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(4-chlorophenyl)methyl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-(2-propoxypyrimidin-5-yl)pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-(2,2,2-trifluoroethoxy)pyrimidin-5-yl]pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-[2-(trifluoromethoxy)ethoxy]pyrimidin-5-yl]pyridazin-1-yl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-[(2-methylphenyl)methyl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-phenylcyclobutyl)acetamide (CID 159013433) is N-[(2S)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(2R)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(4-chlorophenyl)methyl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-(2-propoxypyrimidin-5-yl)pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-(2,2,2-trifluoroethoxy)pyrimidin-5-yl]pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-[2-(trifluoromethoxy)ethoxy]pyrimidin-5-yl]pyridazin-1-yl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-[(2-methylphenyl)methyl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-phenylcyclobutyl)acetamide.

What is the SMILES notation for N-[(2S)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(2R)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(4-chlorophenyl)methyl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-(2-propoxypyrimidin-5-yl)pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-(2,2,2-trifluoroethoxy)pyrimidin-5-yl]pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-[2-(trifluoromethoxy)ethoxy]pyrimidin-5-yl]pyridazin-1-yl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-[(2-methylphenyl)methyl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-phenylcyclobutyl)acetamide?

The canonical SMILES for N-[(2S)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(2R)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(4-chlorophenyl)methyl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-(2-propoxypyrimidin-5-yl)pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-(2,2,2-trifluoroethoxy)pyrimidin-5-yl]pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-[2-(trifluoromethoxy)ethoxy]pyrimidin-5-yl]pyridazin-1-yl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-[(2-methylphenyl)methyl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-phenylcyclobutyl)acetamide is CCCOc1ncc(-c2ccc(=O)n(CC(=O)NC3CCC3)n2)cn1.CC[C@@H](C)NC(=O)Cn1nc(-c2ccc(OC(F)F)nc2)ccc1=O.CC[C@H](C)NC(=O)Cn1nc(-c2ccc(OC(F)F)nc2)ccc1=O.Cc1ccccc1CNC(=O)Cn1nc(-c2ccc(OC(F)F)nc2)ccc1=O.O=C(Cn1nc(-c2ccc(OC(F)F)nc2)ccc1=O)NC1(c2ccccc2)CCC1.O=C(Cn1nc(-c2ccc(OC(F)F)nc2)ccc1=O)NCc1ccc(Cl)cc1.O=C(Cn1nc(-c2cnc(OCC(F)(F)F)nc2)ccc1=O)NC1CCC1.O=C(Cn1nc(-c2cnc(OCCOC(F)(F)F)nc2)ccc1=O)NC1CCC1.

What is the InChIKey of N-[(2S)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(2R)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(4-chlorophenyl)methyl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-(2-propoxypyrimidin-5-yl)pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-(2,2,2-trifluoroethoxy)pyrimidin-5-yl]pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-[2-(trifluoromethoxy)ethoxy]pyrimidin-5-yl]pyridazin-1-yl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-[(2-methylphenyl)methyl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-phenylcyclobutyl)acetamide?

The InChIKey is JSUAIZUCVRFDSY-DPHLWUGDSA-N. The full InChI is InChI=1S/C22H20F2N4O3.C20H18F2N4O3.C19H15ClF2N4O3.C17H18F3N5O4.C17H21N5O3.C16H16F3N5O3.2C16H18F2N4O3/c23-21(24)31-19-9-7-15(13-25-19)17-8-10-20(30)28(27-17)14-18(29)26-22(11-4-12-22)16-5-2-1-3-6-16;1-13-4-2-3-5-14(13)10-23-17(27)12-26-19(28)9-7-16(25-26)15-6-8-18(24-11-15)29-20(21)22;20-14-4-1-12(2-5-14)9-23-16(27)11-26-18(28)8-6-15(25-26)13-3-7-17(24-10-13)29-19(21)22;18-17(19,20)29-7-6-28-16-21-8-11(9-22-16)13-4-5-15(27)25(24-13)10-14(26)23-12-2-1-3-12;1-2-8-25-17-18-9-12(10-19-17)14-6-7-16(24)22(21-14)11-15(23)20-13-4-3-5-13;17-16(18,19)9-27-15-20-6-10(7-21-15)12-4-5-14(26)24(23-12)8-13(25)22-11-2-1-3-11;2*1-3-10(2)20-13(23)9-22-15(24)7-5-12(21-22)11-4-6-14(19-8-11)25-16(17)18/h1-3,5-10,13,21H,4,11-12,14H2,(H,26,29);2-9,11,20H,10,12H2,1H3,(H,23,27);1-8,10,19H,9,11H2,(H,23,27);4-5,8-9,12H,1-3,6-7,10H2,(H,23,26);6-7,9-10,13H,2-5,8,11H2,1H3,(H,20,23);4-7,11H,1-3,8-9H2,(H,22,25);2*4-8,10,16H,3,9H2,1-2H3,(H,20,23)/t;;;;;;2*10-/m......10/s1.

What are the key properties of N-[(2S)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(2R)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(4-chlorophenyl)methyl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-(2-propoxypyrimidin-5-yl)pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-(2,2,2-trifluoroethoxy)pyrimidin-5-yl]pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-[2-(trifluoromethoxy)ethoxy]pyrimidin-5-yl]pyridazin-1-yl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-[(2-methylphenyl)methyl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-phenylcyclobutyl)acetamide?

N-[(2S)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(2R)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(4-chlorophenyl)methyl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-(2-propoxypyrimidin-5-yl)pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-(2,2,2-trifluoroethoxy)pyrimidin-5-yl]pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-[2-(trifluoromethoxy)ethoxy]pyrimidin-5-yl]pyridazin-1-yl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-[(2-methylphenyl)methyl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-phenylcyclobutyl)acetamide has a molecular weight of 3092.37 g/mol, XLogP of 15.91, 56 rotatable bonds, 8 hydrogen bond donors, and 52 hydrogen bond acceptors.

Where does this data come from?

All data for N-[(2S)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(2R)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(4-chlorophenyl)methyl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-(2-propoxypyrimidin-5-yl)pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-(2,2,2-trifluoroethoxy)pyrimidin-5-yl]pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-[2-(trifluoromethoxy)ethoxy]pyrimidin-5-yl]pyridazin-1-yl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-[(2-methylphenyl)methyl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-phenylcyclobutyl)acetamide is sourced from PubChem (CID 159013433), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).